XBiotech enters new employment agreement with CEO John Simard; $1.25M salary, $4.53M bonus baseline

XBiotech Inc.

Base salary unchanged at $1.25M; annual bonus baseline set at $4.53M for 2025, both inflation-adjusted annually.
Severance: 3 years base salary + 3 years base bonus if terminated without cause, disability, or retirement; 80% if for cause.
Upon retirement, CEO to consult for 18 months receiving additional base salary payments plus severance.
Agreement formalizes compensation trends over past 5 years; approved by Compensation Committee of independent directors.
Executive remains CEO and President; no change in leadership roles.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.